From getting the technique right to boosting production capacity, from setting a suitable price to market launch, Germany-headquartered Merck Life Sciences played a crucial role in the story of India’s Covid-19 vaccine making. Be it Covaxin, Covishield, Corbevax or GemCovac19 vaccine, almost every Indian vaccine maker reached out this Bengaluru-based company for assistance when they found themselves in the middle of chaos. Aditya Sharma, head of the company’s bioprocessing business in India, told News18.com in an exclusive interview that the last two years were extremely hustling yet rewarding. For Sharma, it was difficult to decide “who to prioritise and serve...